Concepedia

Martha Hayden-Ledbetter

MH

14

Publications

1.9K

Citations

13

H-Index

2000

Active since

Affiliations

Pacific Northwest Diabetes Research Institute(Current)

University of Washington

Alexion Pharmaceuticals (United States)

Charité - Universitätsmedizin Berlin

Humboldt-Universität zu Berlin

Martha Hayden-Ledbetter is an author at Pacific Northwest Diabetes Research Institute specializing in cell biology, medicine, and immunology.

Top concepts

Publications per year

2000–2014

14

Publications

14

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Ingegerd Hellström, John Raycraft, Martha Hayden-Ledbetter et al. · PubMed · 2003 · 718 citations

, , +15

Characterization of Human Inducible Costimulator Ligand Expression and Function

Alexandra Aicher, Martha Hayden-Ledbetter, William Brady et al. · The Journal of Immunology · 2000 · 241 citations · Full text

Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB

Zhengmao Ye, Ingegerd Hellström, Martha Hayden-Ledbetter et al. · Nature Medicine · 2002 · 155 citations

, , +8

Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical

Zhao Xiaobin, Rosa Lapalombella, Trupti Joshi et al. · Blood · 2007 · 137 citations · Full text

Cutting Edge: CD83 Regulates the Development of Cellular Immunity

Nathalie Scholler, Martha Hayden-Ledbetter, Amber Dahlin et al. · The Journal of Immunology · 2002 · 120 citations · Full text

Rows per page

1–5 of 14